期刊文献+

甲地孕酮对晚期肺癌化疗患者生活质量影响的临床观察 被引量:1

Armor progesterone to later period lung cancer chemotherapy patient quality of life influence clinical observation
原文传递
导出
摘要 目的:探讨甲地孕酮对晚期肺癌化疗患者生活质量的影响.方法:将确诊为晚期肺癌的患者70例随机分为治疗组和对照组,治疗组为甲地孕酮加化疗,于化疗前一天开始服用甲地孕酮,每天一次,每次160㎎,连服2周,对照组为单纯化疗组,观察患者的KPS评分、食欲、体重、消化道反应以及白细胞情况.结果:治疗组KPS评分提高或稳定30例,占85.7%,食欲改善25例,占71.4%,体重增加或无变化28例,占80%,Ⅱ度以下消化道反应28例,占80%,白细胞计数正常27例,占77.1%.两组比较差异有统计学意义(P〈0.005).结论:甲地孕酮可明显减轻化疗患者的副作用,可提高患者生活质量. Objecitve:Discusses the armor progesterone to the later period lung cancer chemotherapy patient quality of life influence. Methods:Will diagnose for the later period lung cancer patient 70 examples divides into the treatment group and the control group stochastically, the treatment group adds the chemotherapy for the armor progesterone, day before will start in the chemotherapy to take the armor progesterone, daily one time, each time 160 mg,including will take 2 weeks, the control group for the pure chemotherapy group,will observe patient's KPS grading,the appetite, the body weight, the digestive tract response as well as the white blood cell situation. Results:The treatment group KPS grading enhances or the stable 30 examples,accounts for 85.7% ,the appetite improves 25 examples,accounts for 71.4 %, the weight gain or does not have changes 28 examples, accounts for 80 %, ⅡFollowing digestive tract responded 28 examples, account for 80 %, the white blood cell counting normal 27 examples, accounts for 77.1 %. Two group of comparison differences have statistics significance (P〈0. 005). Conclusion:The armor progesterone may reduce the chemotherapy patient's side effect obviously, may improve the patient quality of life.
出处 《按摩与康复医学》 2011年第9期3-4,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 甲地孕酮 化疗 肺癌 生活质量 Armor progesterone Chemotherapy Lung cancer Quality of life
  • 相关文献

参考文献7

二级参考文献20

  • 1Wiser W,Berger A.Practical management of chemotherapy-duced nausea and vomiting[J].Oncology (Williston Park),2005,19:637.
  • 2Hesketh PJ,Kris MG,Grunberg SM,et al.Proposal for classifying the acute emetogenicity of cancer chemotherapy[J].J Clin Oncol,1997,15:103.
  • 3Roila F,Donati D,Tamberi S,et al.Delayed emesis:Incidence,pattern,prognostic factors and optimal treatment[J].Support Care Cancer,2002,10:88.
  • 4Fiorica JV,Brunetto VL,Hanjani P,et al.Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma:a Gynecologic Oncology Group study[J].Gynecol Oncol,2004,92(1):10-14.
  • 5Ruiz Garcia V,Juan O,Perez Hoyos S,et al.Megestrol acetate:a systematic review usefulness about the weight gain in neoplastic patients with cachexia[J].Med Clin(Barc),2002,119(5):166-170.
  • 6Tchekmedyian NS,HS Hariri L,Siau J,et al.Megestrol acetate in cancer anorexia and weight loss[J].Cancer,1992,69:1269.
  • 7张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
  • 8Burris HA,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with GEM as first-line therapy for patients with advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15:2403 ~2413.
  • 9Simmons SF,Walker KA,Osterweil D.The effect of megestrol acetate on oral food and fluid intake in nursing home residents:a pilot study[J].J Am Med Dir Assoc,2005,6(3 Suppl):S5 ~ 11.
  • 10Pascual Lopez A,Roque i Figuls M,Urrutia Cuchi G,et al.Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome[J].J Pain Symptom Manage,2004,27(4):360 ~ 369.

共引文献37

同被引文献3

  • 1孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2008:371.
  • 2李志伟,张艳桥,娄长杰,张纯慧,燕飞虎.甲地孕酮对晚期肺癌患者生活质量的改善作用[J].临床肿瘤学杂志,2007,12(8):619-620. 被引量:11
  • 3崔慧娟 李佩文.醋酸甲地孕酮在晚期肿瘤治疗中的应用进展.国外医学:肿瘤学分册,2001,28(6):473-474.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部